A Government Guide to Keeping Insulin Unaffordable: 3 Easy Steps to Hogtie a Market

One thing the public must always keep in mind with regard to medicine is that the regulators and industry are pretty much on the same side.

(From FEE)

Amid this cesspool of indignant commentary, you’re likely to hear one of the biggest misconceptions around: that markets, competition, or capitalism have failed to respond to the patient’s need in creating more affordable insulin. What you won’t hear is how pharma giants have enlisted the FDA, the DEA, the FBI, customs and border security, and a dozen other taxpayer-funded regulatory and enforcement agencies to protect their profit margins.

Click here for the article.